Harvey L. Berger

Biomedical engineering

Implant (medicine)

Intersect ENT

Tranilast

Christodoulos I. Stefanadis

Phosphorylcholine

Drug-eluting stent

Cordis (medical)

Sirolimus

DES

Biomedical engineering

Alacrite

Bioresorbable stent

History of invasive and interventional cardiology

Interventional oncology

Terumo

Verification and validation

Brachytherapy

Cardiac catheterization

Paclitaxel

Implant (medicine)

ICD-9-CM Volume 3

Holter monitor

Valentin Fuster

Blalock-Taussig shunt

Cryoablation

Cardiac magnetic resonance imaging

Radiofrequency ablation

Artificial cardiac pacemaker

Surgery

Cardiothoracic surgery

Cardiopulmonary resuscitation

Cardiac catheterization

Implantation25

• The XIENCE V stent utilizes everolimus, which has been shown to reduce tissue proliferation in the coronary vessels following stent implantation, and is built upon Abbott's MULTI-LINK VISION® Coronary Stent System, the world's market-leading bare metal stent. (hhmglobal.com)
• A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. (springer.com)
• Based on recent concerns over the rare but serious side effect of blood clots or stent thrombosis, FDA asked Medtronic to combine data from all Endeavor trials to determine how often this happened at various points in time following stent implantation. (fiercebiotech.com)
• Modelling chemistry and biology after implantation of a drug-eluting stent. (aimsciences.org)
• that is, does the coating remain in place on the metallic stent or are small particles released downstream as the stent travels through the arteries to the implantation site? (medscape.com)
• We also ask for a smaller subset of patients with protocol-mandated angiography and intravascular ultrasound to assess healing responses and how well the stent is apposed to the artery wall, both immediately post-implantation and in the long term. (medscape.com)
• Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? (semanticscholar.org)
• s w t o t n t b w o the Editor: Presently, occurrence of late stent thrombosis (LST) fter drug-eluting stent implantation is a major clinical concern. (semanticscholar.org)
• A long-term follow-up study revealed recently that ST occurs at a constant rate of 0.6%/year for up to 3 years after rug-eluting stent implantation (1). (semanticscholar.org)
• Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography. (semanticscholar.org)
• Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. (semanticscholar.org)
• Different inflammatory response and oxidative stress in neointimal hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed rabbits. (springermedizin.at)
• The Ultimaster TANSEI DES will be a core component of the currently enrolling MASTER DAPT study, which compares an abbreviated versus prolonged DAPT within current guidelines and instructions for use, following stent implantation in patients presenting with high bleeding risk (HBR) features. (terumo-europe.com)
• Objective To compare the application effect and cost in intracoronary stent implantation between domestic and imported drug eluting stent. (cnki.com.cn)
• Methods A total of 791 coronary heart disease patients undergoing intracoronary stent implantation were selected in a Grade 3 and first-class hospital in 2013,and they were divided into A group( using domestic drug eluting stent,n = 398) and B group( using imported drug eluting stent,n = 393) according to the types of stents. (cnki.com.cn)
• During the intracoronary stent implantation,patients of A group used Shanghai Minimally-invasive Firebird Ⅱ Drug-eluting Stents,while patients of B group received United States Medtronic Endenvor Drug Eluting Stents. (cnki.com.cn)
• Conclusion Domestic and imported drug eluting stent have similar application effect on intracoronary stent implantation,but using domestic drug eluting stent can significantly reduce the medical expenses. (cnki.com.cn)
• The near elimination of stent thrombosis observed between one and four years after implantation shows that everolimus-eluting stents overcome the principal limitation of early generation DES," said investigator Dr Lorenz Räber from the University Hospital of Bern, Switzerland. (healthcanal.com)
• Stent thrombosis occurring more than one year after implantation - commonly referred to as very late stent thrombosis (VLST) - has been observed more frequently in patients treated with early generation DES releasing the drugs paclitaxel or sirolimus than with bare metal stents and has emerged as a distinct entity complicating their use. (healthcanal.com)
• The procedure was completed successfully, including implantation of two drug-eluting stents. (kurzweilai.net)
• Objectives The authors sought to investigate the association between P2Y 12 reaction units (PRU) and the risk of ischemic stroke (IS) after successful coronary drug-eluting stents (DES) implantation. (onlinejacc.org)
• Ein Modell der Stent-Implantation in Maus Halsschlagader beschrieben. (jove.com)
• Assessment of vascular wall responses, including volumetric measurements of vessel, stent, lumen, peri-stent plaque, and intimal hyperplasia, indices of remodeling, stent expansion, and stent-vessel wall apposition in response to biolimus-eluting and bare-metal stent implantation will be performed. (clinicaltrials.gov)
• Since the balloon is immediately deflated after maximal inflation during stent implantation and 80% of the expandable wire mesh of the stent was open surface opposing elastic recoil, the process minimized endothelial damage compared to balloon angioplasty alone [ 5 ]. (mdpi.com)
• It is hoped that gene therapy will be less expensive and affordable because the techniques involved are simpler than those involved in cardiac bypass surgery, heart transplantation and stent implantation. (prnewswire.com)

Implanted with bare-metal stents1

• The number of adverse events experienced by patients implanted with the Endeavor stent was similar to those that occurred in patients implanted with bare-metal stents and existing drug-eluting stents. (fiercebiotech.com)

Sirolimus-elutin2

• Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study. (semanticscholar.org)
• The reduction in stent thrombosis was most prominent between one and four years, resulting in a 67% risk reduction in VLST for the comparison of everolimus-eluting with sirolimus-eluting stents, and a 76 % risk reduction for the comparison of everolimus-eluting with paclitaxel-eluting stents. (healthcanal.com)

20185

• Additionally, increasing per capita income and rising living standards is expected to drive the global Peripheral Drug-Eluting Stents during the forecast period 2018-2025. (globalbankingandfinance.com)
• A removable balloon is as good as a permanent stent implant for opening small blocked arteries, according to late breaking results from the BASKET-SMALL 2 trial presented in a Hot Line Session today at ESC Congress 2018 and simultaneously published in The Lancet. (news-medical.net)
• Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from the GLOBAL LEADERS trial presented today in a Hot Line Session at ESC Congress 2018 and published in The Lancet. (news-medical.net)
• The global market size of Coronary Stent is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. (aarkstore.com)
• The minutes of meeting state: "The Authority deliberated and decided that the NPPA, in any case, shall revisit the pricing of cardiac stents before February 13, 2018. (indianexpress.com)

Second-generation drug-elutin1

• Role of Second-Generation Drug-Eluting Stents and Bypass Grafting. (ingentaconnect.com)

Zilver PTX Drug-Eluti3

• In the United States, the Zilver PTX Drug-Eluting Stent is an investigational device not available for sale at this time. (drugs.com)
• We're excited to present the data on Cook Medical's Zilver PTX Drug-Eluting Stent. (cookmedical.com)
• FDA Panel will discuss, make recommendations and vote on information related to the premarket approval application (PMA) for the Zilver PTX Drug-Eluting Stent. (cookmedical.com)

Global drug-eluti3

• Europe, Middle East & Africa, Asia-Pacific and Americas are having significant growth in global drug-eluting stent market over the past decade and also it is expected to increase its dominance over the forecast period at a CAGR of 5.36% over the (2019-2025) forecast period. (oganalysis.com)
• Global Drug-eluting stent report provides strategic analysis of the Market through key drivers, restraints, challenges and opportunities. (oganalysis.com)
• The research work categorizes the Global Drug eluting stent Market based on product into 2 categories including Polymer Based Coating, Polymer Free Coating. (oganalysis.com)

Polymer-free3

• The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug-coated stent in patients at high risk of bleeding and treated with one-month dual antiplatelet therapy (DAPT) found that both are clinically safe and effective. (news-medical.net)
• The demand for polymer-free drug eluting stents is going to increase considerably with new products entering the market, especially in emerging countries such as Brazil, Mexico, and South Africa. (giiresearch.com)
• VANCOUVER , June 11 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver(R) PTX(R) Drug-Eluting Peripheral Stent. (newswire.ca)

Capped the prices of coronary stents1

• On February 13, the National Pharmaceutical Pricing Authority (NPPA) capped the prices of coronary stents. (indianexpress.com)

Taxus1

• SPIRIT II met its primary endpoint and demonstrated the superiority of XIENCE V to TAXUS on in-stent late loss at six months. (dicardiology.com)

Everolimus-elutin2

• It is against this background that newer generation DES, such as everolimus-eluting stents, have been developed, to improve safety with the application of a more biocompatible polymer, along with a reduction in drug dose and reduced strut thickness. (healthcanal.com)
• mean age 72.8±7.2 years) who had previously received 21 infrapopliteal sirolimus- or everolimus-eluting stents. (octnews.org)

Late lumen loss2

• Primary end points included in-stent late lumen loss and in-stent percent of obstruction at 4 months. (onlinejacc.org)
• The performance will be assessed by measuring the Late Lumen Loss, in-stent and in-segment at six months post procedure. (presseportal.ch)

20195

• Further, the research report presents near term and long term forecast of the global drug eluting stents during the forecast period 2019-2025. (oganalysis.com)
• Global Coronary Stent Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Coronary Stent industry. (aarkstore.com)
• 5.The report estimates 2019-2024 market development trends of Coronary Stent industry. (aarkstore.com)
• In the Drug-Eluting Balloons statistical surveying study, 2019 is considered as the base year, and 2020-2027 is considered as the estimate time frame to anticipate the market size. (galusaustralis.com)
• The Drug-Eluting Balloons market clicked an estimation of ~US$ xx Mn/Bn in 2019. (galusaustralis.com)

Angioplasty3

• Endpoints included event-free survival (EFS), stent integrity by radiographic core laboratory analysis and primary patency by Duplex ultrasound core laboratory analysis (peak systolic velocity ratio 55 institutions in the United States, Japan and Germany, with 241 patients randomized to the Zilver PTX group and 238 to the balloon angioplasty group. (drugs.com)
• Approximately half the balloon angioplasty group experienced acute failure and underwent secondary randomization, assigning 59 and 61 patients to provisional stenting with Zilver BMS and Zilver PTX, respectively. (drugs.com)
• Deployment of a stent overcomes some limitations of balloon angioplasty alone, but provides an acute stimulus for thrombus formation and promotes neointimal hyperplasia. (mdpi.com)

Scaffolds3

• Patients with heart disease commonly receive such stents, narrow metal scaffolds that widen a partly clogged blood vessel. (redorbit.com)
• The National Pharmaceutical Pricing Authority (NPPA) had in February slashed the prices of coronary stents by over 80% and set ceilings for all drug-eluting stents and bioresorbable vascular scaffolds (BVS). (livemint.com)
• Improved results were observed following the insertion of an additional intravascular mechanical support, cylindrical metal scaffolds known as stents [ 5 ]. (mdpi.com)

Medtronic8

• For example, the Endeavor stent from Medtronic was submitted for FDA approval last Nov. 16. (medpagetoday.com)
• Manufactured by Medtronic, Inc., of Minneapolis, the device is a tiny metal mesh tube coated with a small amount of a new drug, zotarolimus, developed only for use on a stent. (fiercebiotech.com)
• GAITHERSBURG, Md., Oct. 11 -- An FDA advisory panel voted unanimously to recommend approval of a zotarolimus-eluting coronary stent made by Medtronic. (medpagetoday.com)
• MINNEAPOLIS Oct. 11, 2005 Medtronic ( NYSE: MDT ) announced that it has submitted its first Pre-Market Approval (PMA) module to the U.S. Food and Drug Administration for the Endeavor Drug-Eluting Coronary Stent system. (webwire.com)
• This action represents the first step by Medtronic in the U.S. approval process for Endeavor stents. (webwire.com)
• Scott Ward, president of Medtronic Vascular in Santa Rosa, Calif., said the company has worked diligently with the FDA to develop a well-designed schedule of modular submissions that meet the agency s requirements for the Endeavor stent and the new molecular entity, ABT-578. (webwire.com)
• The NPPA did not put a separate price cap for biodegradable stents as requested by multinational companies such as India Medtronic, Abbott Healthcare and Boston Scientific India. (indianexpress.com)
• Another stent maker, Medtronic, had also sought to withdraw its Onyx Zotarolimus eluting stents but the NPPA rejected its application. (livemint.com)

Biodegradable stents4

• The increasing adoption of biodegradable stents is mainly driving the growth of the polymer-based coating stents segment. (giiresearch.com)
• Technological advancements, such as the introduction of biodegradable stents primarily, led to the highest revenue generation in the region. (giiresearch.com)
• However, the sub-committee has opined that no information/evidence/data has been generated which changes the opinion and, therefore, the sub-committee reiterated its earlier recommendation and did not agree to exclude bioabsorbable vascular scaffold/biodegradable stents from the two categories of stents currently under price control. (indianexpress.com)
• Consequently, companies such as Boston Scientific India and Abbott Healthcare have requested the NPPA to let them withdraw their latest-generation stents, which include biodegradable stents, from the Indian market. (indianexpress.com)

Cardiovascular11

• As history unfolds in drug-eluting stent treatment, it has become apparent that there is a critical need for new, next-generation platforms with the potential to improve patient care," said Gregg W. Stone, M.D., of Columbia University Medical Center and the Cardiovascular Research Foundation, New York, and principal investigator in the SPIRIT II and III trials. (dicardiology.com)
• Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). (ingentaconnect.com)
• For physicians, surgeons, and scientists working on cardiovascular disorders, Applications of Biotechnology in Cardiovascular Therapeutics serves as an invaluable reference by collecting the essential writings of Dr. Kewal K. Jain on the topics of biotechnology as they relate to cardiovascular disease. (springer.com)
• Comprehensive and up-to-date, Applications of Biotechnology in Cardiovascular Therapeutics will be tremendously useful for those working in life sciences and the pharmaceutical sciences, and the inclusion of some basics of cardiovascular diseases will greatly benefit nonmedical readers as well. (springer.com)
• Growing incidence of cardiovascular diseases, increasing geriatric population and acceptance for minimally invasive endovascular surgeries are the factors striving the growth of Drug-eluting stents market. (oganalysis.com)
• 2. The method of claim 1, wherein a non-toxic chemical route in alkaline conditions at varying temperature and time yields distinct nanostructural features of tunable morphologies on the surface of endovascular prosthesis for improved cardiovascular applications. (google.es)
• A publication of results of a research study in one of the nation's most respected medical journals, which examined the performance of drug-coated stents in cardiovascular disease patients, recently reported in the Journal of the American Medical Association (JAMA), confirmed findings of prior research indicating that commonly used drug-coated stents cause a much higher rate of complications and death than previously thought. (chron.com)
• This illustrates the need for further innovation and research in the stent arena and opens the competitive door for companies like MIV Therapeutics (OTCBB:MIVT), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices," Clark added. (chron.com)
• Its products find applications in various therapeutic areas such as cardiovascular, peripheral vascular, neurovascular and structural heart disease. (bioportfolio.com)
• The material's thermo-mechanical characteristics and its biocompatibility make it ideal for cardiovascular stents, endoscopic instruments, surgical tools and other products. (assemblymag.com)
• Most people associate nitinol with cardiovascular stents. (assemblymag.com)

Metallic stent2

• Nanosecond laser texturing of metallic stent surfaces generates laser-induced periodic surface structures, also referred to as ripples, which can be utilized to promote drug adherence directly to the stent surface. (iastate.edu)
• Eluting Coronary Stent System with the MULTI-LINK VISION® metallic stent system. (dicardiology.com)

Myocardial infarction8

• Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent. (news-medical.net)
• These studies usually involve evaluation of a composite primary endpoint of cardiac death, myocardial infarction, and need for repeat procedure involving the lesion where the stent was placed. (medscape.com)
• A five-year, 5,000-patient post-marketing study with a primary endpoint of very late stent thrombosis and a secondary endpoint of death and/or myocardial infarction. (medpagetoday.com)
• Patients treated with CABG had lower rates of death and of death or myocardial infarction than treatment with a drug-eluting stent. (wikipedia.org)
• Although rare, stent thrombosis is a serious complication, which may result in death or acute myocardial infarction. (healthcanal.com)
• the safety of HIT in acute myocardial infarction patients with drug-eluting stent. (scribd.com)
• Conclusions: HIT is more effective than MCT for improving VO2peak in acute myocardial infarction patients with drug-eluting stent. (scribd.com)
• Treatment of patients with acute myocardial infarction with drug eluting stents (DES) is effective but there remain concerns regarding the long-term safety and adverse effects on the adjacent arterial wall. (clinicaltrials.gov)

Primary endpoint1

• SPIRIT FIRST met its primary endpoint and demonstrated no stent thrombosis out to three years. (dicardiology.com)

Neointimal hyperplasia2

• Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization. (springer.com)
• Delayed neointimal growth, enhanced platelet aggregation, a local hypersensitivity reaction against the polymer coating, stent fracture, and a failure of sirolimus-, paclitaxel-, and tacrolimus-eluting stents to reduce neointimal hyperplasia at 90 and 180 days in animals, when the drug was completely eluted from the stent, are just several examples. (ahajournals.org)

Expandable4

• Stents and similar devices such as stent, stent-grafts, expandable frameworks, and similar implantable medical devices, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. (google.com.au)
• There are wide varieties which is employed various purposes such as in biliary and vascular stents and expandable coronary, and in simple plastic stents which is used for allowing urine to flow easily between the bladder and the kidney. (qyresearchreports.com)
• Stents are expandable wire-mesh devices placed in clogged blood vessels to prop open the vessels to maintain healthy blood flow to the heart or elsewhere in the body," stated SmallCap Sentinel analyst D.R. Clark . (chron.com)
• The first balloon expandable stents were designed from surgical grade stainless steel, and aimed to provide additional mechanical support, limiting vessel recoil and preventing acute occlusion [ 6 ]. (mdpi.com)

20172

• Application # 2017/0367860. (patents.com)
• The respiratory problem segment accounted for the largest market share in 2017, whereas the antimicrobial application segment is expected to register the highest growth rate during the forecast period. (openpr.com)

Arterial4

• F. Bozsak , J. M. Chomaz and A. I. Barakat , Modeling the transport of drugs eluted from stents: Physical phenomena driving drug distribution in the arterial wall, Biomechanics and Modeling in Mechanobiology , 13 (2014), 327-347. (aimsciences.org)
• Extensive application of coronary intravascular procedures has led to the increased need of understanding the injury inflicted to the coronary arterial wall. (eur.nl)
• The magnetic field, comparable to that produced by existing MRI machines, but one-tenth as strong, magnetized both the stents and the nanoparticles, and drove the particles into the stents and the nearby arterial tissue. (redorbit.com)
• Over the past several years, Levy and colleagues have shown similar proofs of concept in other animal studies, using magnetically guided nanoparticles to deliver gene therapy and therapeutic endothelial cells to arterial stents. (redorbit.com)

Lumen4

• A stent for delivering therapeutic agents to a body lumen includes a plurality of circumferential serpentine bands with each band comprising a plurality of struts. (google.com.au)
• A stent is a medical device introduced to a body lumen and is well known in the art. (google.com.au)
• Drug eluting stents have become commonplace, but they effectively slow down healing and endothelium formation in exchange for an open lumen through which blood can flow with little interference. (medgadget.com)
• The angiographic analysis from the SCRIPPS (Scripps coronary radiation to inhibit proliferation post-stenting) trial at three years showed a reduction of the minimum lumen diameter in irradiated patients but not in the placebo group, 11 with a further increase in target lesion revascularisation (TLR) between 3-5 years in the irradiated patients only. (bmj.com)

Market70

• HTF MI published a new industry research that focuses on Drug Eluting Stents (DES) market and delivers in-depth market analysis and future prospects of Global Drug Eluting Stents (DES) market. (medgadget.com)
• The research covers the current market size of the Global Drug Eluting Stents (DES) market and its growth rates based on 5 year history data along with company profile of key players/manufacturers. (medgadget.com)
• The in-depth information by segments of Drug Eluting Stents (DES) market helps monitor future profitability & to make critical decisions for growth. (medgadget.com)
• The information on trends and developments, focuses on markets and materials, capacities, technologies, CAPEX cycle and the changing structure of the Global Drug Eluting Stents (DES) Market. (medgadget.com)
• The market is growing at a very rapid pace and with rise in technological innovation, competition and M&A activities in the industry many local and regional vendors are offering specific application products for varied end-users. (medgadget.com)
• Global Drug Eluting Stents (DES) (Thousands Units) and Revenue (Million USD) Market Split by Product Type such as Cobalt-chromium alloy Stents, Magnesium alloy Stents, Tyrosine polycarbonate Stents, Nitinol Stents, Platinum chromium alloy Stents, Stainless steel Stents & Other Materials. (medgadget.com)
• Following would be the Chapters to display the Global Drug Eluting Stents (DES) market. (medgadget.com)
• The global market for drug-eluting stents is expected to reach $6 billion by 2015, according to a new report. (fiercepharma.com)
• This number has dropped to 10 percent of patients since drug-eluting stents entered the U.S. market in 2003. (fiercebiotech.com)
• Analyst projections for the drug-eluting stent (DES) market estimated that the total number of DES implanted in 2010 would go beyond 4.5 million worldwide. (ahajournals.org)
• The report includes forecast and analysis for the Durable Drug Eluting Stents market on a global and regional level. (prismcoalition.org)
• The study covers drivers and limitations of the Durable Drug Eluting Stents market along with the impact they have on the trade over the forecast period. (prismcoalition.org)
• Additionally, the report covers the study of possibilities available in the Durable Drug Eluting Stents market on a global level. (prismcoalition.org)
• The report aims to present a study of Global Durable Drug Eluting Stents Market along with accurate segmentation of market by type, solution, application and five major geographical regions. (prismcoalition.org)
• Global Durable Drug Eluting Stents market is supposed to witness a high increase during the forecast years due to expanding risk of data theft and firm government regulation. (prismcoalition.org)
• Along with strategically examining the key micro markets, the paper also focuses on industry-specific drivers, restraints, possibilities and challenges in the Durable Drug Eluting Stents market. (prismcoalition.org)
• The research methodology for Research Corridor's Durable Drug Eluting Stents market report utilizes a key of top-down and bottom-up research arrangements. (prismcoalition.org)
• The Drug Eluting Bioabsorbable Stents Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Drug Eluting Bioabsorbable Stents Market. (worldwidemarketreports.com)
• With the use of historic data from (period), the Drug Eluting Bioabsorbable Stents Market report offers Y-o-Y growth and CAGR until 2026. (worldwidemarketreports.com)
• The global market for Drug Eluting Bioabsorbable Stents Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020. (worldwidemarketreports.com)
• Growth opportunities in the global Drug Eluting Bioabsorbable Stents Market across major regions during the forecast period. (worldwidemarketreports.com)
• Role of emerging markets in the global Drug Eluting Bioabsorbable Stents Market and the scenario during the 2020-2026. (worldwidemarketreports.com)
• New trends and advancements in the global Drug Eluting Bioabsorbable Stents Market. (worldwidemarketreports.com)
• The Europe Drug Eluting Stents Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Drug Eluting Stents industry. (qyresearchreports.com)
• The Drug Eluting Stents market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status. (qyresearchreports.com)
• The research report investigates into the growth trajectory of the Europe drug eluting stents industry 2015 market research report market in order to provide valued insights to reader for understanding the structure of the market better. (qyresearchreports.com)
• The Europe drug eluting stents industry 2015 market research report market can be thus classified on the basis of end users, raw materials, products, applications, and regions. (qyresearchreports.com)
• Different trends that may negatively or positively impact the growth of the Europe drug eluting stents industry 2015 market research report market have also been measured in the report. (qyresearchreports.com)
• The vendor landscape has also been evaluated efficiently in the report of the Europe drug eluting stents industry 2015 market research report market. (qyresearchreports.com)
• Rising investments on healthcare and increasing patients coupled with expanding the market opportunities in developing nations are the factors boosting the growth of Drug-eluting stents market. (oganalysis.com)
• Additionally, growing of acceptance of stents as a feasible treatment and increase in the number of patients that are preferring drug-eluting stents are anticipated to strive the market growth. (oganalysis.com)
• The decline in average selling price of drug eluting stents is hampering the market growth. (oganalysis.com)
• The report provides detailed research and analysis into Drug-eluting stent industry long term trends, recent advancements, technological insights and new market dynamics. (oganalysis.com)
• Further, the list of top Drug-eluting stent companies as well as company wise SWOT analysis, current strategic interests and financial results are included in the Nebulizers report in order to provide detailed information on the market. (oganalysis.com)
• Drug eluting stent Market- Forecasts by Segments- Product and Application by geography. (oganalysis.com)
• 1.The report provides key statistics on the market status of the Coronary Stent manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. (aarkstore.com)
• 4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. (aarkstore.com)
• Further, expansion of the applications of non conventional modes of drug delivery such as pulmonary, nasal and transdermal in disease conditions other than respiratory and skin, especially in chronic disease conditions such as diabetes, CNS are also boosting the market. (marketsandmarkets.com)
• The polymer-based coating stent segment was dominating the global market and is estimated to remain dominant throughout the forecast period. (giiresearch.com)
• This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions. (reportsnreports.com)
• An expert panel, which was asked by PMO to examine possibility of excluding such stents from price control as 'cheaper' Chinese devices are entering Indian market, has said it has found no data to back the move. (indianexpress.com)
• The domestic stent firms have stated that they have been gaining market share after the price cap. (indianexpress.com)
• Multinational companies have a share of more than 50 per cent in India's stent market, according to industry sources. (indianexpress.com)
• A person privy to the development said the company's representatives met National Pharmaceutical Pricing Authority (NPPA) officials on Tuesday, seeking to withdraw its next-generation product "Synergy" stent from the market. (livemint.com)
• Additionally, Meril Life Sciences-manufacturer of indigeneous BVS stents-has halted the launch of new stents in the market. (livemint.com)
• This report categorizes the drug-device combination market by products, applications, and technology, each of which is further categorized into its individual submarket. (marketsandmarkets.com)
• No single report by any other publisher provides market data for all market segments (i.e. products, services, applications, ingredients, and technology) covering the four geographies of North America, Europe, Asia Pacific, and ROW. (marketsandmarkets.com)
• Based on Application, the Stent Grafts Market studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm. (reportbuyer.com)
• The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Stent Grafts Market including AptusEndosystem, Bolton Medical, GRIKIN Advanced Materials, Johnson & Johnson, LifeTech Scientific, Lombard Medical Technologies, Terumo, TriVascular Technologies, and Wl Gore & Associates. (reportbuyer.com)
• The FPNV Positioning Matrix evaluates and categorizes the vendors in the Stent Grafts Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. (reportbuyer.com)
• 1. What is the market size and forecast of the Global Stent Grafts Market? (reportbuyer.com)
• 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Stent Grafts Market during the forecast period? (reportbuyer.com)
• 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Stent Grafts Market? (reportbuyer.com)
• 4. What is the competitive strategic window for opportunities in the Global Stent Grafts Market? (reportbuyer.com)
• 5. What are the technology trends and regulatory frameworks in the Global Stent Grafts Market? (reportbuyer.com)
• 6. What are the modes and strategic moves considered suitable for entering the Global Stent Grafts Market? (reportbuyer.com)
• The report on the Drug-Eluting Balloons Market gives a foot perspective on the present continuing inside the Drug-Eluting Balloons market. (galusaustralis.com)
• Further, the report likewise considers the effect of the novel COVID-19 pandemic on the Drug-Eluting Balloons market and offers an away from of the anticipated market variances during the estimate time frame. (galusaustralis.com)
• In 2027, the Drug-Eluting Balloons market is spectated to outperform ~US$ xx Mn/Bn with a CAGR of xx% over the estimate time frame. (galusaustralis.com)
• Region is required to represent a critical piece of the overall industry, where the Drug-Eluting Balloons market size is anticipated to blow up with a CAGR of xx% during the estimate time frame. (galusaustralis.com)
• The report inspects each Drug-Eluting Balloons market player as per its piece of the pie, creation impression, and development rate. (galusaustralis.com)
• Further, the Drug-Eluting Balloons market study portrays the ongoing dispatches, understandings, R&D undertakings, and business systems of the market players including. (galusaustralis.com)
• The whole analysis of the Drug-Eluting Balloons market. (galusaustralis.com)
• Information regarding advanced development and technology innovation for the Drug-Eluting Balloons market. (galusaustralis.com)
• The Drug-Eluting Balloons market is examined and showcase size data is given by region. (galusaustralis.com)
• The examination report on the global Drug-Eluting Balloons market offers a treasury of economic situations and strategies wherein the market has been acting in various circumstances. (galusaustralis.com)
• Biotechnology applications recorded for the biggest share of the Q-TOF mass spectrometry market in 2016towing to the increasing use of Q-TOF mass spectrometers for quantitative and qualitative analyses in the quickly increasing research areas of proteomics and metabolomics. (reportlinker.com)
• The industry report examines the Q-TOF mass spectrometry market and aims at estimating the market value and the future increase potential of this market established on different segments including application and area. (reportlinker.com)
• The Global drug eluting stents market research report 2016 market has multinational players functioning on the field with different varieties of products to deliver. (qyresearchreports.com)
• The global drug-device combination products market is segmented based on product, application, end user, and region. (openpr.com)

Coatings4

• Comparison of the test results with mathematically modeled data acquired using finite element methods demonstrated a good agreement between modeled data and experimental results indicating that gel hydrophobicity will only influence release in cases of fast releasing stent coatings. (springer.com)
• Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. (springer.com)
• Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes. (springer.com)
• The newer generations of drug-eluting stents use different platforms, different drugs, and improved polymer coatings. (medpagetoday.com)

Forecast1

• The biodegradable polymer-based drug eluting stents are anticipated to have a high demand during the forecast period due to aminimally invasive technique and lesser risk of late stent thrombosis. (giiresearch.com)